马志敏,陈喆,杨毅,李顺宝,郭丽珠

• 1:首都医科大学附属北京同仁医院心血管中心

摘要(Abstract)：

目的分析冠心病患者的中心动脉血压参数和冠状动脉粥样硬化病变及其严重程度的关系。方法测量146例接受冠脉造影检查的冠心病患者肱动脉血压、升主动脉血压,计算患者的冠脉病变支数及Syntax积分,分析血压参数和冠脉病变的关系。结果肱动脉收缩压(BSBP)有高于中心动脉收缩压(CSBP)的趋势,但差异无统计学意义(129.2±14.1)mmHg比(125.0±13.4)mmHg,t=1.62,P=0.10;肱动脉舒张压(BDBP)有低于中心动脉舒张压(CDBP)的趋势,但差异无统计学意义(74.7±11.0)mmHg比(77.9±11.3)mmHg,t=1.88,P=0.07;肱动脉脉压(BPP)高于中心动脉脉压(CPP),(54.5±11.8)mmHg比(50.0±11.1)mmHg,t=2.51,P<0.05。年龄和中心动脉脉压对冠脉病变Syntax积分有独立的预测价值。结论经导管测量的中心动脉血压参数可预测冠脉病变的严重程度。

关键词(KeyWords)： 中心动脉压;肱动脉血压;冠状动脉疾病;冠状血管造影术

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 马志敏,陈喆,杨毅,李顺宝,郭丽珠

参考文献(References)：

• [1]Willinams B,Lacv PS,Thom SM,et al.Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes.Principal results of the conduit artery function evaluation(CAFE)Study.Circulation,2006,113:1213-1225.
• [2]http://www.syntaxscore.com.
• [3]Lindholm LH,Ibsen H,Dahl f B,et al.Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study(LIFE):a randomised trial against atenolol.Lancet,2002,359:1004-1010.
• [4]ALLHATOfficers and Coordinators for the ALLHATCollaborative Research Group.Major outcomes in moderately hypercholesterolemic,hypertensive patients randomized to pravastatin vs usual care:the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial(ALLHAT-LLT).JAMA,2002,288:2998-3007.
• [5]Jankowski P,Kawecka-Jaszcz K,Czarnecka D.Ascending aortic blood pressure waveform is related to coronary atherosclerosis in hypertensive as well as in normotensive subjects.Blood Press,2007,16:246-253.
• [6]Roman MJ,Devereux RB,Kizer JR,et al.Central pressure more strongly relates to vascular disease and outcome than does brachial pressure:the Strong Heart Study.Hypertension,2007,50:197-203.
• [7]Weber T,Auer J,O′Rourke M,et al.Arterial stiffness,wave reflections,and the risk of coronary artery disease.Circulation,2004,109:184-189.
• [8]Nrnberger J,Keflioglu-Scheiber A,Opazo Saez AM,et al.Augmentation index is associated with cardiovascular risk.J Hypertens,2002,20:2407-2414.
• [9]Zuo JL,Li Y,Yan ZJ,et al,Validation of the central blood pressure estimation by the SphygmoCor system in Chinese.Blood Press Monit.2010Mar30.Epub ahead of print.
• [10]Ohte N,Saeki T,Miyabe H,et al,Relationship between blood pressure obtained from the upper arm with a cuff-type sphygmomanometer and central blood pressure measured with a catheter-tipped micromanometer.Heart Vessels,2007,22:410-415.
• [11]Franklin S,Khan S,Wong N,et al.Is pulse pressure useful in predicting risk for coronary heart disease-The Framingham Heart Study.Circulation,1999,100:354-360.
• [12]Zakopoulos NA,Lekakis JP,Papamichael CM,et al.Pulse pressure in normotensives:a marker of cardiovascular disease.Am J Hyprtens,2001,14:195-199.
• [13]王宏宇,胡大一,马志敏,等.脉压与冠状动脉病变严重性的关系研究.中华心血管病杂志,2000,31:83-86.
• [14]Roman MJ,Devereux RB,Kizer JR,et al.Central pressure more strongly relates to vascular disease and outcome than does brachial pressure the strong heart study.Hypertension,2007,50:197-203.